AAWHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Ascend Wellness Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.39−0.00 (-0.73%)
Close on Oct 19, 2026
- Market cap
- $79.60M
- P/E (TTM)
- –
- Dividend yield
- –
Ascend Wellness Holdings, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Retail revenue | $339.56M | $372.24M | $371.17M | $305.94M | $231.93M | $103.86M | $11.20M | 67.8% | -8.8% |
| Third-party wholesale revenue | $161.02M | $189.36M | $147.42M | $99.99M | – | – | – | 32.2% | -15.0% |
| Wholesale revenue | – | – | $264.07M | $181.75M | $148.48M | $57.45M | $1.97M | – | – |
By region
From the segment and revenue-disaggregation notes of Ascend Wellness's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.